CoChat

GSK3β: A Master Player in Depressive Disorder Pathogenesis and Treatment Responsiveness

Open access

The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.

Abstract

Glycogen synthase kinase 3β (GSK3β), originally described as a negative regulator of glycogen synthesis, is a molecular hub linking numerous signaling pathways in a cell. Specific GSK3β inhibitors have anti-depressant effects and reduce depressive-like behavior in animal models of depression. Therefore, GSK3β is suggested to be engaged in the pathogenesis of major depressive disorder, and to be a target and/or modifier of anti-depressants’ action. In this review, we discuss abnormalities in the activity of GSK3β and its upstream regulators in different brain regions during depressive episodes. Additionally, putative role(s) of GSK3β in the pathogenesis of depression and the influence of anti-depressants on GSK3β activity are discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells9030727

Cites

211 of 211 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Neurotransmitters acting through protein kinases and phosphatases regulate glycogen synthase kinase 3β (GSK3β) activity. GSK3β influences the strength of excitatory and inhibitory synapses. Green arrows represent activation, red arrows represent inhibition, black arrows represent translocation. Abbreviations: NMDAR: N-methyl-d-aspartate receptor, AMPAR: α-amino-3-hydroxy-5-methyl-4-izoxazole propionic acid receptor, GABABR: γ-aminobutyric acid receptor type B, D1/2/3R: dopamine receptors, 5-HT1/2A/7R: serotonin receptors, α1A/α2/βAR: adrenergic receptors, PKA: protein kinase A, AKT: protein kinase B, PKC: protein kinase C, PP2A/2B: protein phosphatases 2A/2B, CaMK2: calcium/calmodulin dependent protein kinase 2, GSK3β: glycogen synthase kinase 3β.
Figure 1 Neurotransmitters acting through protein kinases and phosphatases regulate glycogen synthase kinase 3β (GSK3β) activity. GSK3β influences the strength of excitatory and inhibitory synapses. Green arrows represent activation, red arrows represent inhibition, black arrows represent translocation. Abbreviations: NMDAR: N-methyl-d-aspartate receptor, AMPAR: α-amino-3-hydroxy-5-methyl-4-izoxazole propionic acid receptor, GABABR: γ-aminobutyric acid receptor type B, D1/2/3R: dopamine receptors, 5-HT1/2A/7R: serotonin receptors, α1A/α2/βAR: adrenergic receptors, PKA: protein kinase A, AKT: protein kinase B, PKC: protein kinase C, PP2A/2B: protein phosphatases 2A/2B, CaMK2: calcium/calmodulin dependent protein kinase 2, GSK3β: glycogen synthase kinase 3β.CC BY · PubMed Central
Figure 2 GSK3β is a part of neurotrophic and pro-inflammatory factors signaling pathways. Green arrows represent activation, red arrows represent inhibition. Green-red arrow denotes a dual, dependent on the physiological state of a cell, action of GSK3β. Abbreviations: WNT: Wingless-related integration site, LRP5/6: low-density lipoprotein receptor-related protein 5 and 6, DSH: Disheveled, 5-HT1BR—serotonin 1B receptor, ERK: extracellular signal-regulated kinase, APC: adenomatous polyposis coli, BDNF: brain-derived neurotrophic factor, TrkB: tropomyosin receptor kinase B, PI3K: phosphoinositide 3-kinase, AKT: protein kinase B, IL-1β: interleukin 1β, IL-1R: interleukin 1β receptor, TNFα: tumor necrosis factor α, TNFR: tumor necrosis factor α receptor, IKK: IκB kinase, IκBα: nuclear factor of light polypeptide gene enhancer in B-cells inhibitor α, NF-κB: Nuclear factor κ-light-chain-enhancer of activated B cells, mTOR: mammalian target of rapamycin, REDD1: regulated in development and DNA damage response-1, DNMT3a: DNA methyltransferase 3a, GSK3β: glycogen synthase kinase 3β.
Figure 2 GSK3β is a part of neurotrophic and pro-inflammatory factors signaling pathways. Green arrows represent activation, red arrows represent inhibition. Green-red arrow denotes a dual, dependent on the physiological state of a cell, action of GSK3β. Abbreviations: WNT: Wingless-related integration site, LRP5/6: low-density lipoprotein receptor-related protein 5 and 6, DSH: Disheveled, 5-HT1BR—serotonin 1B receptor, ERK: extracellular signal-regulated kinase, APC: adenomatous polyposis coli, BDNF: brain-derived neurotrophic factor, TrkB: tropomyosin receptor kinase B, PI3K: phosphoinositide 3-kinase, AKT: protein kinase B, IL-1β: interleukin 1β, IL-1R: interleukin 1β receptor, TNFα: tumor necrosis factor α, TNFR: tumor necrosis factor α receptor, IKK: IκB kinase, IκBα: nuclear factor of light polypeptide gene enhancer in B-cells inhibitor α, NF-κB: Nuclear factor κ-light-chain-enhancer of activated B cells, mTOR: mammalian target of rapamycin, REDD1: regulated in development and DNA damage response-1, DNMT3a: DNA methyltransferase 3a, GSK3β: glycogen synthase kinase 3β.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 211 references

Cited by

See all 84

Metadata

Authors
Duda, P., Hajka, D., Wójcicka, O., Rakus, D., & Gizak, A.
Affiliations
University of Wrocław (PL)
Corresponding author
  • Duda, Przemysław
  • Gizak, Agnieszka
Venue
Cells
Publisher
MDPI AG
Published
2020-03-16
Volume
9
Issue
3
Pages
727
ISSN
2073-4409 (ISSN-L)
OpenAlex
W3012493302
Cited by
84
References
211
Citations by year
2026: 15 · 2025: 20 · 2024: 11 · 2023: 12 · 2022: 12 · 2021: 11 · 2020: 3
FWCI
1.24
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Polish Ministry of Science and Higher Education (UMO-2015/19/B/NZ1/00332)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
GSK3β, glycogen synthase kinase-3β, major depressive disorder, depression pathogenesis, antidepressant response, GSK-3β inhibitors, antidepressant mechanism, upstream regulators, brain regions, depression-like behavior
MeSH terms
Neuroprotection, Glycogen Synthase Kinase 3 beta, Animals, Brain, Major Depressive Disorder, Hippocampus, Humans, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GSK3β: A Master Player in Depressive Disorder Pathogenesis and Treatment Responsiveness. https://app.cochat.ai/papers/10.3390/cells9030727
The paper
Duda, P., Hajka, D., Wójcicka, O., Rakus, D., & Gizak, A. (2020). GSK3β: A Master Player in Depressive Disorder Pathogenesis and Treatment Responsiveness. Cells. https://doi.org/10.3390/cells9030727

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.